UBS Group
GRI

UBS Group’s GRI Bio GRI Stock Holding History

UBS Group’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.71K Sell
4,920
-3,802
-44% -$8.42K ﹤0.01% 8654
2026
Q1 		$20K Buy
+8,722
New +$32.5K ﹤0.01% 7938
2025
Q4 		– Sell
-1
Closed -$56 – 10771
2025
Q3 		$56 Sell
1
-551
-100% -$25.5K ﹤0.01% 10006
2025
Q2 		$19.9K Buy
552
+436
+376% +$18.2K ﹤0.01% 8444
2025
Q1 		$10.4K Sell
116
-78
-40% -$19.6K ﹤0.01% 8631
2024
Q4 		$76.4K Buy
194
+43
+28% +$14.7K ﹤0.01% 7041
2024
Q3 		$25.9K Buy
151
+113
+297% +$45.5K ﹤0.01% 7211
2024
Q2 		$34.5K Buy
38
+37
+3,700% +$88.1K ﹤0.01% 6974
2024
Q1 		$6.1K Buy
+1
New +$8.53K ﹤0.01% 7483
2023
Q4 		– Hold
0
– – – 8474
2023
Q3 		– Hold
0
– -$3.82K – 9648
2023
Q2 		– Hold
0
– – – 7598
2023
Q1 		– Hold
0
– – – 8825
2022
Q4 		– Hold
0
– – – 9117
2022
Q2 		– Hold
0
– -$17K – 10553
2022
Q1 		– Hold
0
– – – 7649
2021
Q4 		– Hold
0
– – – 8064
2021
Q3 		– Hold
0
– – – 7879
2021
Q2 		– Hold
0
– – – 8665

Other funds holding GRI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

UBS Group's GRI Position: Q2 2026 in Review

UBS Group reduced its GRI Bio (GRI) stake by 44% in Q2 2026, selling an estimated $8.42K and leaving 4,920 shares worth $8.71K. The position accounts for ﹤0.01% of the portfolio, ranked #8654.

UBS Group first reported a position in GRI in Q1 2024 and has held it in 9 quarters since. The position peaked at $76.4K in Q4 2024. 8 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • UBS Group held 4,920 shares of GRI Bio worth $8.71K as of Q2 2026.
  • UBS Group sold 3,802 GRI Bio shares in Q2 2026, an estimated $8.42K.
  • GRI Bio made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8654 holding.
  • UBS Group first reported a position in GRI Bio in Q1 2024 and has held it in 9 quarters since.
  • UBS Group's GRI Bio position peaked at $76.4K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.